Real-World Data Built for Precision,
Trusted by Regulators
The only FDA-trusted solution for generating RWE with patient-level, multi-modal data—accelerating safety and effectiveness studies, built for rare and complex diseases.
Drive Faster, More Cost-Effective Study Execution
Launch in weeks, not quarters, with tailored no‑code workflows
Instantly adapt study tasks without disrupting sites
Monitor progress with real-time dashboards
Unite Multi-Modal Data—Zero Stitching
Integrate clinical, imaging, genomics, PROs & device data at the patient level
60,000-site EMR network for clinical RWD collection, trusted by 7 of the top 10 U.S. AMCs & leading EU centers
Disease-specific outcomes & markers for rare & complex conditions
Patient‑Centric for Long-Term Engagement
Enable decentralized participation for better patient diversity
Capture longitudinal data for multi-year evidence generation
Boost patient engagement by returning personal insights & relevant services
Real-World Studies We Power
Ready to talk to our RWE Team?
Learn about how Embleema helps reduce trial costs and delivers regulatory-ready RWE.